Introduction
From Clinical Trials to RWE in PsA & PsO
Objectives
•Present current scientific evidence, including clinical trials, Real-world data, and illustrative case studies, on the management of PsA & PsO
•Communicate Ixekizumab and Baricitinib value proposition to highlight what the product may mean to people living with Psoriatic Arthritis (PsA)& Plaque Psoriasis (PsO) respectively.
This Course For :
Physician
( Dermatology , Rheumatology )
Resident / Fellow
( Dermatology , Rheumatology )
Speaker
Dr Ahmed Ismail
Consultant & Head of Dermatology Dept.
Dr. Erfan & Bagedo General Hospital – Jeddah.
Lecturer of Dermatology & Venerology
Al Azhar Faculty of Medicine
Dr Zeyad Al Zahrani
Consultant Rheumatologist - Section Head
King Khalid Medical City - Jeddah
Ministry of National Guard Health Affairs.
Dr. Abdulrahman Albahlool
CONSULTANT
DERMATOLOGY, VENEROLOGY AND LASER DEPARTMENT
KING FAHD HOSPITAL - Jeddah.
VICE PRESIDENT GENERAL MEDICAL COMMITTEE MAKKAH REGION
Provided by :
Price
Course Fee
FREE
FREE
Contact Information
Organization : Virtual Medical AcademyPhone : 920008161
Email : [email protected]
Free
19 Nov 2025 To 19 Nov 2025 -
09:15 PM To 10:30 PM 
Certificate Available 
Online
Add to Calendar
11/19/2025 09:15 PM
11/19/2025 10:30 PM
Asia/ Riyadh
Transition from Clinical Trials to RWE in Psoriatic Arthritis & Plaque Psoriasis
Transition from Clinical Trials to RWE in Psoriatic Arthritis & Plaque Psoriasis
https://medicalacademy.org/portal/event/view/2487
